MLH1 and endometrial cancer: Objective responses were noted in both ovarian and endometrial cancers across histologic subtypes and grades and mechanisms of dMMR (MLH1 hypermethylation, somatic mutation or germline mutation in an MMR gene) (Extended Data Table 2).